Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

OHI vs AHR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

OHI Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)

OHI Overall Winner 6-Pillar Tally: OHI 5 – 1 AHR Matrix Metrics: OHI 8 – 2 AHR

As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over American Healthcare REIT, Inc. (AHR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas AHR carries 35.9/100 (SELL) at $57.87 (58.4x Forward P/E, 6.8% operating margin).

  • Growth vs. Quality Trade-Off: OHI earns the overall head-to-head edge with a stronger Unified Composite Score (50.5/100 HOLD vs. AHR 35.9/100 SELL) and -0.04β · 29% Vol risk profile, whereas AHR leads top-line expansion (+29.4% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile AHR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 64.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About OHI vs AHR
OHI NYSE Head-to-Head Winner
Omega Healthcare Investors Inc.
Real Estate Investment Trusts
$46.91
-0.29% 1D
Market Cap $15.0B
TTM Revenue $1.26B
Forward P/E 22.6x
Beta / 30D Vol -0.04β · 29% Vol
Unified Composite Score
50.5 / 100 HOLD
Tech 50.0 Fund 55.0 Flow 71.0 Mom 41.7
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope 0.5%) with fading momentum, RSI 50
RSI-14: 49.6 · SMA20: $47.08 · SMA50: $46.44
AHR NYSE
American Healthcare REIT, Inc.
Real Estate Investment Trusts
$57.87
+0.16% 1D
Market Cap $13.6B
TTM Revenue $2.67B
Forward P/E 58.4x
Beta / 30D Vol 0.03β · 32% Vol
Unified Composite Score
35.9 / 100 SELL
Tech 50.0 Fund 30.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 64
RSI-14: 64.1 · SMA20: $55.37 · SMA50: $53.46

6-Pillar Scorecard Institutional Category Breakdown (OHI 5 – 1 AHR)

Columns: Metric · OHI · AHR
1. Valuation Multiples OHI
Forward P/E 22.6x 58.4x
Trailing P/E 19.0x 119.7x
PEG Ratio 11.99x N/M
EV / Revenue 14.9x 5.1x
2. Growth & Scale AHR
Revenue Growth (YoY) -0.6% +29.4%
Earnings Growth (YoY) -55.4% -57.6%
TTM Revenue (USD) $1.26B $2.67B
Market Cap $15.0B $13.6B
3. Profitability & Quality OHI
Gross Margin 95.8% 20.3%
Operating Margin 62.6% 6.8%
Net Profit Margin 60.5% 3.6%
Return on Equity (ROE) 14.5% 2.3%
4. Balance Sheet & Cash Flow OHI
Cash Generation (TTM) $855M $497M EBITDA
Cash Flow Margin 67.9% 18.6% EBITDA Mgn
Net Cash / Leverage $3.83B Net Debt (0.73x D/E) $23.91 Book/Sh · 2.3% ROE
Dividend Yield 5.61% 1.69%
5. Options & Positioning OHI
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 26.9% (65th %ile) 31.1% (27th %ile)
Put/Call OI Skew 0.71x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Distribution NEUTRAL · Neutral
6. R&D & Supply-Chain Moat OHI
OpEx & R&D Intensity 33.2% of Rev ($418M) 13.5% of Rev ($361M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role REIT - Healthcare Facilities Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: OHI (8) vs AHR (2)
Institutional Metric OHI AHR Criterion Row Edge
Market Capitalization
Scale
$15.0B $13.6B Larger Scale OHI
Trailing P/E Ratio
Valuation
19.0x 119.7x Lower Multiple OHI
Forward P/E Ratio
Valuation
22.6x 58.4x Lower Multiple OHI
Revenue Growth (YoY)
Growth
-0.6% +29.4% Higher Growth AHR
Operating Margin (TTM)
Profitability
62.6% 6.8% Higher Margin OHI
Net Profit Margin
Profitability
60.5% 3.6% Higher Margin OHI
Return on Equity (ROE)
Capital Efficiency
14.5% 2.3% Higher ROE OHI
52-Week Range Position
Momentum
46% ($42–$52) 89% ($45–$60) Stronger Trend AHR
Beta / 30D Volatility
Risk Regime
-0.04β · 29% Vol 0.03β · 32% Vol Lower Realized Risk OHI
Unified Institutional Score
Composite Signal
50.5 / 100 (HOLD) 35.9 / 100 (SELL) Higher Composite OHI
Trailing 12M Revenue (USD)
Operating Scale
$1.26B $2.67B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
95.8% 20.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
11.99x PEG · 14.9x EV/Rev N/M PEG · 5.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$855M ($3.83B Net Debt (0.73x D/E)) $497M EBITDA ($23.91 Book/Sh · 2.3% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AHR +5.93 pp
OHI: +2.79% · AHR: +8.72%
3M Horizon AHR +5.32 pp
OHI: +1.02% · AHR: +6.34%
6M Horizon AHR +18.44 pp
OHI: -2.91% · AHR: +15.53%
1Y Horizon AHR +11.99 pp
OHI: +7.97% · AHR: +19.96%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OHI vs AHR. Trailing 12-month operating profitability (OHI 62.6% vs AHR 6.8%) and valuation multiples (OHI 22.6x vs AHR 58.4x Forward P/E) are benchmarked directly in Pillar 4 below.

OHI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.26B
Gross Margin95.8%
Op. Margin62.6%
ROE / Fwd P/E14.5% · 22.6x
AHR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.67B
Gross Margin20.3%
Op. Margin6.8%
ROE / Fwd P/E2.3% · 58.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
OHI CONSOLIDATION
80d in phase · OBV DISTRIBUTION
Current IV 26.9%
IV Percentile 65th %ile
Put/Call OI Skew 0.71x (Call-Skewed)
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact OHI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AHR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 31.1%
IV Percentile 27th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AHR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
OHI Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $15.0B market capitalization and 62.6% operating margin.
OpEx & R&D Reinvestment 33.2% of Rev ($418M)
90D Engineering Disclosures 0 Published
AHR Moat Profile Cyclical / Execution-Driven Positioning
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $13.6B market capitalization and 6.8% operating margin.
OpEx & R&D Reinvestment 13.5% of Rev ($361M)
90D Engineering Disclosures 0 Published

Investor FAQ OHI vs AHR Key Questions & Quantitative Answers

As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over American Healthcare REIT, Inc. (AHR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas AHR carries 35.9/100 (SELL) at $57.87 (58.4x Forward P/E, 6.8% operating margin). Growth vs. Quality Trade-Off: OHI earns the overall head-to-head edge with a stronger Unified Composite Score (50.5/100 HOLD vs. AHR 35.9/100 SELL) and -0.04β · 29% Vol risk profile, whereas AHR leads top-line expansion (+29.4% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile AHR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 64.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AHR leads the Growth & Scale pillar: OHI posts -0.6% YoY revenue growth and -55.4% YoY earnings growth on $1.26B TTM revenue (95.8% gross margin, 62.6% operating margin), compared with AHR at +29.4% YoY revenue growth and -57.6% YoY earnings growth on $2.67B TTM revenue (20.3% gross margin, 6.8% operating margin). On trailing 12-month operating scale, OHI generates $1.26B in USD-normalized revenue versus $2.67B for AHR. In operating R&D and SG&A reinvestment, OHI deploys 33.2% of Rev ($418M) (0 90-day corporate R&D disclosures) versus 13.5% of Rev ($361M) (0 disclosures) for AHR.

OHI screens cheaper on headline valuation multiples. OHI trades at 22.6x Forward P/E, 19.0x Trailing P/E, 11.99x PEG, and 14.9x EV/Revenue (67.9% FCF margin), whereas AHR trades at 58.4x Forward P/E, 119.7x Trailing P/E, N/M PEG, and 5.1x EV/Revenue (18.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OHI (14.5% ROE) versus AHR (2.3% ROE) capital efficiency.

In options market volatility and institutional positioning, OHI carries 26.9% implied volatility (65th %ile, Elevated (60th–80th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.04β · 29% Vol realized risk). By comparison, AHR carries 31.1% implied volatility (27th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.03β · 32% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.